Last updated: March 27, 2026 (Week 13)

AI — The Cognitive Revolution

Tier 1: Foundation Model Labs

CompanyStatusValuationWhy It Matters
OpenAIPrivate, IPO expected 2026/27$730–840BCore of the agent revolution. This week: “Spud” model finished pretraining, Codex plugin ecosystem launched (Slack, Figma, Notion integration), and Sora was shut down after 6 months ($15M/day costs vs $2.1M lifetime revenue). IPO focus intensifies.
AnthropicPrivate, IPO possible 2026/27$380BEnterprise standard. This week: Data leak revealed “Mythos” — next-generation model with “step change” in reasoning/coding capabilities. Pentagon designation continues but enterprise adoption accelerates. IPO-ready supermodel incoming.
Google DeepMindPart of Alphabet (GOOGL)Gemini 2.0 family. Google Cloud AI infrastructure. Kairos Power nuclear deal.
Meta AIPart of Meta (META)Llama open-source models. Massive AI infrastructure investments. Oklo deal for nuclear power. Ordering millions of Vera Rubin GPUs.
DeepSeekPrivate (China)UndisclosedV4 model (trillion-parameter, multimodal) imminent. Working with Huawei on chip independence. Proves China’s open-source AI is competitive.

Tier 2: AI Infrastructure & Compute

CompanyTickerWhy It Matters
NVIDIANVDAGTC 2026 made the agent stack tangible: new focus on agentic tooling, inference infrastructure, and the next compute roadmap. NVIDIA remains the gatekeeper not just for training, but for the operating layer of agentic AI.
CoreWeaveCRWVAI cloud pure-play. Still one of the cleanest public neocloud bets, but with growing legal overhang and financing sensitivity. A reminder that infrastructure upside and balance-sheet risk travel together.
CerebrasIPO ~April 2026AWS partnership this week put Cerebras directly into the inference-speed conversation. That matters: the market is shifting from training bragging rights toward real-time agent workloads.
AMDAMDAlternative to NVIDIA for AI training. MI300 series.
BroadcomAVGOCustom AI chips for hyperscalers.

Tier 3: Agent Economy & Applications

CompanyStatusWhy It Matters
CoinbaseCOINAgentic Wallets live since Feb 2026. >50M transactions. x402 protocol. Bridge between AI agents and crypto.
KiteTokenFirst “AI Payment Blockchain.” Layer 1 for the autonomous economy. +140% in 90 days.
Perplexity AIPrivateAI search engine. CoreWeave deal for GB200 cluster. Inference-focused.
RoboForcePrivateYZi Labs led a $52M round this week. Important because it shows fresh venture money flowing into AI-driven robotics, not just into model labs.

Robotics — AI Gets Bodies

Humanoid Robots

CompanyStatusWhy It Matters
Tesla (Optimus)TSLAOptimus remained mostly narrative this week, but Tesla showcased the robot at AWE Shanghai and kept the cadence of turning concept into product theater. The key question remains manufacturing, not demos.
Figure AIPrivateFigure is still one of the strongest Western humanoid names, but it had a relatively quieter week. That itself matters: the hype cycle is widening from a few stars to a full competitive field.
UnitreePrivate (China)Reuters reported this week that Unitree is planning a Shanghai IPO, a meaningful signal that China’s humanoid champions are maturing from viral demos into capital-markets stories.
XPeng (IRON)XPEVNew factory in Guangzhou. Large-scale production by end 2026. China’s answer to Optimus.
Neura RoboticsPrivate (Germany)€1B funding from Tether at €4B valuation. Europe’s most significant humanoid player. Crypto capital funds physical AI.
AgilityPrivateRebranded from “Agility Robotics” (March 2026). Digit robots at Toyota, Mercado Libre. “Labor redefinition platform.”
AI2 RoboticsPrivate$144M Series B (Feb 2026). Allen Institute spin-off.
Boston DynamicsHyundai subsidiary (HYMTF)Atlas (electric). CEO Robert Playter resigned. Atlas-DeepMind partnership. All 2026 deployments sold out.
ApptronikPrivateMercedes-Benz partnership. Transitioning from lab to kitting/toting.
SundayPrivateNew household-robotics entrant reportedly reached a $1.15B valuation this month. Early, but notable as consumer humanoid ambition starts attracting serious capital.

Crypto — Machine Money

Protocols & Layer 1/2

AssetTickerWhy It Matters
BitcoinBTCStill the reserve asset of the crypto stack. Mid-March positioning data points to a more constructive long-term-holder setup even as macro volatility stays high.
EthereumETHPrice remains softer than activity, but Ethereum still dominates stablecoins, RWAs, and account abstraction. That makes it the likeliest base layer for serious agent-wallet infrastructure.
SolanaSOLFastest L1. Growing DeFi ecosystem. Stablecoin volume exploding.
Arbitrum / OptimismARB / OPLayer 2 for microtransactions. Essential for M2M payments.
Circle (USDC)IPO expectedStablecoin infrastructure remains central to the machine-economy thesis. Regulatory clarity is inching closer, while USDC keeps compounding its advantage as programmable settlement money.

AI × Crypto Convergence

ProjectStatusWhy It Matters
Paradigm Fund IVVC fund ($1.5B)Explicit pivot from pure crypto VC to AI + Robotics + Crypto. First top-tier convergence fund.
a16z Crypto Fund V$2B fundClosing planned H1 2026.
Fetch.aiFETAgent network on blockchain. Machine-to-machine transactions.
Ocean ProtocolOCEANDecentralized data market for AI training.
Render NetworkRNDRDecentralized GPU compute for AI/3D.
FilecoinFILDecentralized storage. AI data infrastructure.
x402Open protocolThe most concrete bridge yet between APIs and on-chain payments. If agents are going to buy compute, data, or services, x402-style payment rails matter.

Regulation

TopicStatusImpact
US Market Structure BillDraft submittedXRP, SOL, LTC, HBAR, DOGE, LINK as commodities. $75M fundraising exemption without SEC.
GENIUS Act (Stablecoins)OCC rules proposedFederal stablecoin regulation. Limits on yield. Published in Federal Register March 2.
EU MiCAIn effectEuropean crypto framework. Compliance overhead.
EU AI ActHigh-risk provisions Aug 2, 2026The compliance clock keeps tightening. This week’s policy discussion shifted toward streamlining and possible deadline adjustments, but the strategic reality is unchanged: Europe is becoming a forcing function for enterprise AI compliance.

Energy — The Invisible Bottleneck

Nuclear & SMR

CompanyTickerWhy It Matters
NuScale PowerSMRNuScale announced a new partnership with Ebara Elliott Energy to position SMRs for petrochemical power use. The market still worries about execution and litigation, but the commercialization push is real.
OkloOKLOThis week brought milestone updates around first-reactor construction and radioisotope production. Oklo remains the purest public bet on nuclear power for AI-era load growth.
Kairos PowerPrivateGoogle deal for nuclear power. Salt-cooled reactor.
Constellation EnergyCEGLargest US nuclear operator. Microsoft Three Mile Island restart.
CamecoCCJWorld’s largest publicly traded uranium producer.

Brain-Computer Interfaces

CompanyStatusWhy It Matters
NeuralinkPrivate ($9.7B)Reuters reporting this week reinforced Neuralink’s lead, with a Beijing-backed rival openly saying China trails by roughly three years. Leadership in BCI is starting to look like a geopolitical moat.
SynchronPrivate ($200M Series D)Stentrode (minimally invasive). Apple and NVIDIA partnerships. 5-year implant experience documented.
Merge LabsPrivate ($850M)OpenAI-backed ($250M seed). Non-invasive BCIs. Bridging biological and artificial intelligence.
ParadromicsPrivate ($105M+)Highest demonstrated information transfer rates (>200 bps). NIH and DARPA backed.
Science Corp.Private ($230M Series C)Founded by ex-Neuralink president. PRIMA retinal implant. Could be first commercial BCI. CE approval mid-2026.
NeuroXessPrivate (China)Patient controlled cursor <1 week after implant. China’s BCI push: public use in 3–5 years.
GestalaPrivate (China)New Chinese BCI startup that raised $21M just two months after launch. A sign that the category is broadening beyond Neuralink and Synchron.

Longevity & Biotech

CompanyStatusWhy It Matters
Immorta BioPrivateImmorta’s dramatic mouse-lifespan data continued to ripple through the field and was accepted for presentation at IMMUNOLOGY2026. Still early, but one of the more provocative longevity signals on the board.
Unity BiotechnologyUBXSenolytic therapies. Clinical stage.
Altos LabsPrivateBezos-backed. Cellular reprogramming.
CalicoAlphabet subsidiaryLongevity research. Deep pockets.
JuvenescencePrivatePhase 2 proof-of-concept trial 2026. Metabolic/fibrotic diseases. Ventures include Juvenomics.
R1PrivateLaunched this week with $77.5M for chronic kidney disease. Not a pure longevity company, but relevant to healthspan biotech capital formation.

📋 About This Watchlist

This is a living document, updated every Friday as part of the Convergence Thesis weekly deep research. Companies are tracked across all six pillars of the thesis: AI, Robotics, Crypto, Energy, BCIs, and Longevity. Ticker links go to Yahoo Finance for real-time quotes.

New entries are added when they demonstrate relevance to the convergence of these domains. Want updates? Subscribe to the weekly newsletter →